$HRTX News Article - Heron Therapeutics Announces Filing of a Supplemental New Drug Application for Significant Expansion of ZYNRELEF Indication Statement Based on Successful Outcome of FDA Type C Meeting
https://marketwirenews.com/news-releases/hero...94624.html